Tadalafil forventes ikke at medføre en klinisk signifikant inhibition eller induktion af clearance for lægemidler, som metaboliseres via CYP450- isoformer.
Tadalafil is not expected to cause clinically significant inhibition or induction of the clearance of medicinal products metabolised by CYP450 isoforms.